Nanobiotix S.A.
NBTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | -$0 | $0 | $0 | $0 |
| % Growth | -132.1% | 658.1% | 80.4% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 79.4% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | 502.4% | -65.4% | -925.8% | -1,722.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | 586.9% | -109.6% | -1,194.4% | -1,775.7% |
| EPS Diluted | -1.44 | -1.08 | -1.64 | -1.35 |
| % Growth | -33.3% | 34.1% | -21.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |